ELRIG reveals keynote speakers as the industry prepares to explore the next generation of drug research and innovation
London, United Kingdom, 11 June 2026 – The global drug discovery community is preparing for one of its most anticipated events of the year as ELRIG has announced the keynote speakers for its Drug Discovery 2026 conference in London. The event, which marks the 20th anniversary of ELRIG’s flagship conference, will bring together researchers, scientists, biotechnology companies, pharmaceutical leaders, and technology innovators to discuss the future of medicine development.
Scheduled to take place at ExCeL London on October 14 and 15, the conference is expected to attract thousands of professionals from across the life sciences sector. Over the years, the event has grown into a major platform for sharing scientific breakthroughs, discussing emerging technologies, and fostering collaboration across the drug discovery ecosystem.
The newly announced keynote speakers represent a diverse range of expertise, reflecting the increasingly multidisciplinary nature of modern drug research. Their presentations will focus on some of the industry’s most important themes, including advanced therapeutics, artificial intelligence in research, precision medicine, and innovative approaches to developing new treatments.
As pharmaceutical and biotechnology companies face growing pressure to accelerate research timelines while improving success rates, conferences such as Drug Discovery 2026 are becoming increasingly important. They provide opportunities for researchers to exchange ideas, learn about cutting edge technologies, and explore strategies for overcoming challenges in drug development.
Artificial intelligence, machine learning, automation, and data driven research are expected to feature prominently throughout the conference agenda. These technologies are reshaping how scientists identify drug targets, analyze biological data, and design potential therapies. Industry experts believe that combining advanced computational tools with scientific expertise could significantly improve the efficiency of future drug discovery programs.
The conference will also provide a valuable networking platform for professionals from academia, biotechnology startups, pharmaceutical companies, and research organizations. By bringing together experts from different disciplines, ELRIG aims to encourage collaboration and inspire new approaches to tackling complex healthcare challenges.
As the life sciences sector continues to evolve rapidly, Drug Discovery 2026 is expected to offer important insights into the trends and technologies shaping the next era of medical innovation. The event highlights the industry’s ongoing commitment to advancing research and delivering better therapies for patients around the world.
